Vanguard Group’s Kodiak Sciences KOD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$64.7M Buy
2,313,395
+363,103
+19% +$7.44M ﹤0.01% 2035
2025
Q3
$31.9M Buy
1,950,292
+127,991
+7% +$1.1M ﹤0.01% 2391
2025
Q2
$6.8M Buy
1,822,301
+133,486
+8% +$473K ﹤0.01% 3097
2025
Q1
$4.74M Buy
1,688,815
+6,606
+0.4% +$35.9K ﹤0.01% 3192
2024
Q4
$16.7M Sell
1,682,209
-2,920
-0.2% -$16.8K ﹤0.01% 2671
2024
Q3
$4.4M Buy
1,685,129
+29,690
+2% +$78.9K ﹤0.01% 3313
2024
Q2
$3.89M Buy
1,655,439
+991
+0.1% +$3.36K ﹤0.01% 3357
2024
Q1
$8.7M Buy
1,654,448
+10,978
+0.7% +$53.8K ﹤0.01% 3039
2023
Q4
$5M Buy
1,643,470
+10,454
+0.6% +$23.3K ﹤0.01% 3291
2023
Q3
$2.94M Buy
1,633,016
+3,438
+0.2% +$12.1K ﹤0.01% 3462
2023
Q2
$11.2M Sell
1,629,578
-32,323
-2% -$198K ﹤0.01% 2874
2023
Q1
$10.3M Buy
1,661,901
+4,745
+0.3% +$33.2K ﹤0.01% 2919
2022
Q4
$11.9M Buy
1,657,156
+11,073
+0.7% +$79.5K ﹤0.01% 2877
2022
Q3
$12.7M Buy
1,646,083
+53,125
+3% +$516K ﹤0.01% 2833
2022
Q2
$12.2M Sell
1,592,958
-766,522
-32% -$5.38M ﹤0.01% 2881
2022
Q1
$18.2M Sell
2,359,480
-610,430
-21% -$23.8M ﹤0.01% 2828
2021
Q4
$252M Buy
2,969,910
+24,489
+0.8% +$2.49M 0.01% 1465
2021
Q3
$283M Sell
2,945,421
-42,740
-1% -$3.95M 0.01% 1367
2021
Q2
$278M Buy
2,988,161
+50,665
+2% +$4.86M 0.01% 1416
2021
Q1
$333M Buy
2,937,496
+101,876
+4% +$13.9M 0.01% 1238
2020
Q4
$417M Buy
2,835,620
+442,045
+18% +$49.3M 0.01% 978
2020
Q3
$142M Sell
2,393,575
-79,766
-3% -$4M ﹤0.01% 1493
2020
Q2
$134M Buy
2,473,341
+560,336
+29% +$31.6M ﹤0.01% 1516
2020
Q1
$91.3M Buy
1,913,005
+84,125
+5% +$5.05M ﹤0.01% 1576
2019
Q4
$132M Buy
1,828,880
+899,619
+97% +$32.7M ﹤0.01% 1623
2019
Q3
$13.4M Buy
929,261
+165,789
+22% +$2.17M ﹤0.01% 2676
2019
Q2
$8.93M Buy
763,472
+378,544
+98% +$3.37M ﹤0.01% 2922
2019
Q1
$2.51M Buy
384,928
+122,569
+47% +$906K ﹤0.01% 3377
2018
Q4
$1.86M Buy
+262,359
New +$2.32M ﹤0.01% 3399

Other funds holding KOD

Vanguard Group's KOD Position: Q4 2025 in Review

Vanguard Group increased its Kodiak Sciences (KOD) stake by 19% in Q4 2025, buying an estimated $7.44M and bringing the position to 2,313,395 shares worth $64.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2035.

Vanguard Group first reported a position in KOD in Q4 2018 and has held it in 29 quarters since. The position peaked at $417M in Q4 2020. 158 funds tracked by Wall St. Rank hold KOD as of Q4 2025.

  • Vanguard Group held 2,313,395 shares of Kodiak Sciences worth $64.7M as of Q4 2025.
  • Vanguard Group bought 363,103 Kodiak Sciences shares in Q4 2025, an estimated $7.44M.
  • Kodiak Sciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2035 holding.
  • Vanguard Group first reported a position in Kodiak Sciences in Q4 2018 and has held it in 29 quarters since.
  • Vanguard Group's Kodiak Sciences position peaked at $417M in Q4 2020.
  • 158 funds tracked by Wall St. Rank held Kodiak Sciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.